Table 4.

New investigational agents in the treatment of myeloma.

PS-341 Millenium Pharm 
Thalidomide derivatives Celgene Corp 
2ME2 EntreMed 
Neovastat Aeterna Labs 
R 11 5777 (FTI) Janssen/CTEP 
Genasense (Bcl-2) Genta Inc. 
Trisenox (arsenic triOx) CTI 
SU5416 CTEP 
PS-341 Millenium Pharm 
Thalidomide derivatives Celgene Corp 
2ME2 EntreMed 
Neovastat Aeterna Labs 
R 11 5777 (FTI) Janssen/CTEP 
Genasense (Bcl-2) Genta Inc. 
Trisenox (arsenic triOx) CTI 
SU5416 CTEP 
View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal